Literature DB >> 9641297

Rising incidence of oesophageal adenocarcinoma in men in Australia.

R V Lord1, M G Law, R L Ward, G G Giles, R J Thomas, V Thursfield.   

Abstract

Adenocarcinomas of the oesophagus and of the gastric cardia have been reported to be increasing in incidence in many countries, while the incidence of squamous cell carcinoma of the oesophagus is stable and non-cardia gastric cancers are decreasing in incidence. Age-standardized incidence rates for the years 1982-1993 for oesophageal adenocarcinoma and non-adenocarcinoma, and gastric cardia and non-cardia cancers were calculated based on state cancer registry incidence data. Time trends in the age-standardized rates were assessed using linear regression. A consistent increasing trend in the incidence of oesophageal adenocarcinoma in men was seen in all states of Australia and was statistically significant in all states except South Australia. There were no consistent nationwide trends in the incidence of oesophageal adenocarcinoma in women, although a trend towards an increase in the incidence of this cancer reached statistical significance (P < 0.05) in three states (New South Wales, Victoria, Queensland). There were no important trends in the incidence of oesophageal non-adenocarcinoma in either men or women. There were no consistent nationwide changes in the incidence of gastric cardia cancer in either men or women, although this cancer was significantly increasing in Tasmania in both men and women. The incidence of cancer of the stomach not arising at the gastric cardia was significantly decreasing in men in all states and was also decreasing in women in all states, although in women this decrease was statistically significant only in New South Wales, Victoria and Western Australia. There has been a dramatic increase in the incidence of oesophageal adenocarcinoma in men in Australia. The incidence of this cancer in men is now approximately equal with that of non-adenocarcinoma of the oesophagus. The incidence of non-cardia stomach cancer continues to fall.

Entities:  

Mesh:

Year:  1998        PMID: 9641297     DOI: 10.1111/j.1440-1746.1998.tb00646.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  22 in total

1.  Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence.

Authors:  R V Lord; D Salonga; K D Danenberg; J H Peters; T R DeMeester; J M Park; J Johansson; K A Skinner; P Chandrasoma; S R DeMeester; C G Bremner; P I Tsai; P V Danenberg
Journal:  J Gastrointest Surg       Date:  2000 Mar-Apr       Impact factor: 3.452

2.  Norman Barrett, "doyen of esophageal surgery".

Authors:  R V Lord
Journal:  Ann Surg       Date:  1999-03       Impact factor: 12.969

3.  High intake of folate from food sources is associated with reduced risk of esophageal cancer in an Australian population.

Authors:  Torukiri I Ibiebele; Maria Celia Hughes; Nirmala Pandeya; Zhen Zhao; Grant Montgomery; Nick Hayward; Adèle C Green; David C Whiteman; Penelope M Webb
Journal:  J Nutr       Date:  2010-12-22       Impact factor: 4.798

4.  Helicobacter pylori infection and the risks of Barrett's oesophagus: a population-based case-control study.

Authors:  Aaron P Thrift; Nirmala Pandeya; Kylie J Smith; Adèle C Green; Nicholas K Hayward; Penelope M Webb; David C Whiteman
Journal:  Int J Cancer       Date:  2011-08-17       Impact factor: 7.396

5.  The sinister significance of dysphagia.

Authors:  M S Grannell; S Kelly; S Shannon; A L Chong; T N Walsh
Journal:  Ir J Med Sci       Date:  2001 Oct-Dec       Impact factor: 1.568

6.  Management and outcomes of localized esophageal and gastroesophageal junction cancer in older patients.

Authors:  X Qu; J Biagi; A Banashkevich; C D Mercer; L Tremblay; A Mahmud
Journal:  Curr Oncol       Date:  2015-12       Impact factor: 3.677

7.  The risk of Barrett's esophagus associated with abdominal obesity in males and females.

Authors:  Bradley J Kendall; Graeme A Macdonald; Nicholas K Hayward; Johannes B Prins; Suzanne O'Brien; David C Whiteman
Journal:  Int J Cancer       Date:  2012-10-30       Impact factor: 7.396

8.  Esophageal cancer in Canada: trends according to morphology and anatomical location.

Authors:  Michael C Otterstatter; James D Brierley; Prithwish De; Larry F Ellison; Maureen Macintyre; Loraine D Marrett; Robert Semenciw; Hannah K Weir
Journal:  Can J Gastroenterol       Date:  2012-10       Impact factor: 3.522

9.  Exercise and the Prevention of Oesophageal Cancer (EPOC) study protocol: a randomized controlled trial of exercise versus stretching in males with Barrett's oesophagus.

Authors:  Brooke M Winzer; Jennifer D Paratz; Marina M Reeves; David C Whiteman
Journal:  BMC Cancer       Date:  2010-06-16       Impact factor: 4.430

10.  Dendritic cells in Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Yuri V Bobryshev; Dinh Tran; Murray C Killingsworth; Michael Buckland; Reginald V N Lord
Journal:  J Gastrointest Surg       Date:  2008-08-07       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.